Publication | Open Access
<i>In Vitro</i> and <i>In Vivo</i> Selective Antitumor Activity of a Novel Orally Bioavailable Proteasome Inhibitor MLN9708 against Multiple Myeloma Cells
322
Citations
42
References
2011
Year
Our preclinical study supports clinical evaluation of MLN9708, alone or in combination, as a potential MM therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1